Deep Medicine Acquisition... (DMAQ)

AI Score

Unlock

2.96

-5.43 (-64.72%)

At close: Jan 31, 2024, 9:00 PM

Deep Medicine Acquisition Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020
Period Ending	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Revenue	90K	90K	90K	90K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	45K	60K	60K	60K	60K	60K	60K	60K	91K	76K	61K	46K	n/a
Gross Profit	45K	30K	30K	30K	-60K	-60K	-60K	-60K	-91K	-76K	-61K	-46K	n/a
Operating Income	-1.75M	-746.11K	-2.31M	-2.57M	-1.89M	-2.68M	-941.44K	-457.28K	-383.27K	-230.67K	-136.89K	-105.39K	n/a
Interest Income	90.69K	90.69K	552.16K	552.16K	552.16K	552.16K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-1.56M	-554.6K	-449.81K	-342.66K	142.44K	-638.75K	-551.97K	-414.05K	-290.09K	-154.67K	-75.89K	-59.4K	n/a
Net Income	-1.55M	-612.16K	59.79K	297.35K	780.28K	67.51K	-412.87K	-405.36K	-290.09K	-154.67K	-75.89K	-59.4K	n/a
Selling & General & Admin	1.57M	1.6M	2M	1.94M	1.56M	1.3M	663.25K	409.91K	292.27K	154.67K	75.89K	59.4K	n/a
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	339.4K	307.8K	288.92K	245K	45K	45K	45K	30K	30K	15K	n/a	n/a	n/a
Operating Expenses	1.88M	1.87M	2.24M	2.14M	1.56M	1.3M	663.25K	409.91K	292.27K	154.67K	75.89K	59.4K	n/a
Interest Expense	n/a	n/a	n/a	n/a	12.63K	12.63K	12.63K	12.63K	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.91M	1.91M	2.27M	2.17M	1.58M	1.3M	663.25K	409.91K	292.27K	154.67K	75.89K	59.4K	n/a
Income Tax Expense	99.69K	168.1K	-399.06K	-640.01K	-637.85K	-723.44K	-250.05K	-151.14K	-247.85K	-230.67K	-136.89K	-105.39K	n/a
Shares Outstanding (Basic)	4.36M	4.39M	4.61M	2.31M	15.39M	16.43M	16.43M	8.74M	12.35M	16.43M	16.43M	n/a	16.43M
Shares Outstanding (Diluted)	4.36M	4.39M	4.61M	2.31M	15.39M	16.43M	16.43M	8.74M	12.35M	16.43M	16.43M	n/a	16.43M
EPS (Basic)	-0.48	-0.36	-0.27	-0.22	0.04	-0.01	-0.04	-0.04	-0.02	-0.01	-0.00	n/a	n/a
EPS (Diluted)	-0.48	-0.36	-0.27	-0.22	0.04	-0.01	-0.04	-0.04	-0.02	-0.01	-0.00	n/a	n/a
EBITDA	1.61M	132.26K	-585.47K	-102.83K	-2.36M	-888.44K	-170.72K	-187.22K	-75.89K	-75.89K	-75.89K	-59.4K	n/a
EBIT	-859.97K	-859.97K	-2.13M	-2.52M	-1.84M	-1.84M	-570.97K	-185.72K	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	1.07M	-1.01M	-351.48K	n/a	-1.42M	723.44K	171.28K	55.87K	93.18K	128.75K	113.75K	98.75K	52.75K